NASDAQ · Medical Distribution · USD
Synergy CHC Corp. (SNYR) Stock Analysis
Synergy CHC Corp. (SNYR) is a Medical Distribution stock listed on NASDAQ and quoted in US Dollar.
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
SNYR Key Statistics
As of Sep 4, 2026Trading
- Open
- $0.11
- Previous Close
- $0.11
- Day's Range
- 0.10–0.11
- 52-Week Range
- 0.08–2.96
- Volume
- 624.80K
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 0.64
Valuation
- Market Cap
- $1.53M
- P/E Ratio
- unprofitable
- Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
- 0.68
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 0.06
- EPS (ttm)Profit attributable to each share over the last twelve months.
- −1.51
Financials (FY)
- Revenue (FY)
- $30.38M−12.78%
- Net Income (FY)
- −$12.34M−680.77%
- Profit marginThe share of revenue left as profit after all costs and taxes.
- −56.98%
- Shares Outstanding
- 14.90M
- 1-Year Return
- −95.60%
Dividend and dates
- Avg Volume
- 4.88M
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
SNYR Stock Return by Calendar Year
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | −94.46% |
| 2025 | −57.73% |
| 2024 (partial year) | −51.11% |
As of September 4, 2026.
SNYR Revenue and Earnings by Fiscal Year
FY ends December| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $30.38M | −$12.34M | −40.6% |
| 2024 | $34.83M | $2.12M | 6.1% |
| 2023 | $42.78M | $6.34M | 14.8% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $30.38M | $20.30M | −$1.80M | −$12.34M | −40.6% |
| 2024 | $34.83M | $23.64M | $5.80M | $2.12M | 6.1% |
| 2023 | $42.78M | $32.08M | $10.81M | $6.34M | 14.8% |
Annual figures as reported, in the company's reporting currency. As of December 31, 2025.
SNYR Valuation vs Medical Distribution Median
Median of 13 stocks| Metric | SNYR | Medical Distribution median | vs median |
|---|---|---|---|
| P/S ratio | 0.06 | 0.36 | 0.2x the median |
| Profit margin | −56.98% | −4.03% | 53.0 pts below |
Medians across 13 Medical Distribution stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.
Recent News
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.
Related Medical Distribution Stocks
McKesson Corporation
$105.86B
CORCencora, Inc.
$63.15B
CAHCardinal Health, Inc.
$57.49B
HSICHenry Schein, Inc.
$10.01B
AHGAkso Health Group
$726.49M
FOCLEDAP TMS S.A.
$190.70M
Popular Healthcare Stocks
Eli Lilly and Company
$1.02T
JNJJohnson & Johnson
$663.28B
ABBVAbbVie Inc.
$453.19B
MRKMerck & Co., Inc.
$370.89B
UNHUnitedHealth Group Incorporated
$356.47B
